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The human hexokinase II (HK2) has been suggested as a potential therapeutic target 
for the development of drugs against dengue virus (DENV) infection. In this paper, 
compounds with potential HK2 inhibitory activity have been identified using ligand-
based and structure-based virtual screening approaches. Ligand-based drug design 
was performed by using Ultra-Fast Shape Recognition with Atom Types (UFSRAT) and 
Ultrafast Shape Recognition with CREDO Atom Types (USRCAT) programmes by 
utilising 2-Deoxyglucose (2-DG) as the query molecule, which is a known HK2 inhibitor. 
The molecules identified from the programmes showed great similarity to 2-DG with 
scores ranged from 0.78-0.85 and 0.88-0.97 for UFSRAT and USRCAT, respectively. The 
analogues were docked against the crystal structure of HK2 (PDB ID: 2NZT) in complex 
with alpha-D-glucose (GLC) and beta-D-glucose-6-phosphate (BG6) by using AutoDock 
Vina programme, on both A and B chains where the active sites were located. The 
docking hits for molecules from UFSRAT showed binding energies ranged from -7.1 to -4.8 
kcal/mol when docked on chain A, while the hits for chain B showed scores ranged 
from -6.7 to -4.8 kcal/mol. On the other hand, the binding energies for molecules from 
USRCAT when docked on both A and B chains were similar, which ranged from -7.0 to -
5.2 kcal/mol. The hits bind firmly at the cavities, where both GLC and BG6 were oriented 
towards the active sites of HK2. Taken together, this study has successfully discovered 
compounds which have potentials as potent inhibitors of HK2, thus pave the path 
towards the development of dengue therapeutics. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
